Biodexa Pharmaceuticals (BDRX) Return on Sales (2015 - 2021)
Biodexa Pharmaceuticals (BDRX) posted Return on Sales of 30.08% for Q4 2020, down 31.52% sequentially from 22.87% in Q3 2020, and down 3004.0% YoY from 1.04% in Q1 2020.
Biodexa Pharmaceuticals (BDRX) Return on Sales (2015 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported Return on Sales for 4 years, with the latest figure at 30.08% in Q4 2020.
- Quarterly Return on Sales fell 3004.0% year-over-year to 30.08% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 0.44% (changed N/A YoY) and the FY2023 annual result came in at 0.21%, down 7.0% from the prior year.
- Return on Sales slipped to 30.08% in Q4 2020 per BDRX's latest filing, from 22.87% in the prior quarter.
- Over five years, Return on Sales peaked at 0.04% in Q4 2019 and troughed at 30.08% in Q4 2020.
- A 3-year average of 13.29% and a median of 11.52% in 2016 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2016 and 2020: Return on Sales declined 11 bps in 2016, then slumped 3004 bps in 2020.
- Over 3 years, Return on Sales stood at 0.16% in 2016, then surged by 74 bps to 0.04% in 2019, then slumped by 72962 bps to 30.08% in 2020.
- According to Business Quant data, Return on Sales over the past three periods registered 30.08%, 22.87%, and 0.04% for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -0.16% |
| Dec 31, 2020 | -30.08% |
| Sep 10, 2020 | -22.87% |
| Dec 31, 2019 | -0.04% |
| Dec 31, 2016 | -0.16% |
| Dec 31, 2015 | -0.05% |